Nifedipine for the Maintenance Tocolysis of Preterm Labor: Comparison to Placebo in a Prospective, Randomized, Double Blind Trial
Information source: Stanford University
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Obstetric Labor, Premature
Intervention: nifedipine (Drug)
Phase: N/A
Status: Completed
Sponsored by: Stanford University Official(s) and/or principal investigator(s):
Yasser Yehia El-Sayed, Principal Investigator, Affiliation: Stanford University
Summary
Comparing nifedipine to placebo for the maintenance tocolysis of preterm labor
Clinical Details
Official title: Nifedipine for the Maintenance Tocolysis of Preterm Labor: Comparison to Placebo in a Prospective, Randomized Double Blind Trial
Study design: Treatment, Randomized, Double-Blind, Placebo Control, Single Group Assignment
Primary outcome: Achieving 37 weeks gestation
Secondary outcome: Incidence of recurrent preterm laborNeonatal outcomes
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Female.
Criteria:
Inclusion Criteria:
- arrested preterm labor
Exclusion Criteria:
- ruptured membranes
- fetal distress
- placenta previa
- placental abruption
- maternal medical contraindication to tocolysis
Locations and Contacts
Stanford University School of Medicine, Stanford, California 94305, United States
Additional Information
Starting date: November 2001
Last updated: March 21, 2008
|
